Maria Hasan | Chemistry | Research Excellence Award

Published on by NESIN Awards

Dr. Maria Hasan | Chemistry | Research Excellence Award

Researcher | VSB – Technical University of Ostrava | Czech Republic

Dr. Maria Hasan is a materials chemistry researcher whose work spans graphene synthesis, hetero-doping, and advanced carbon-based nanomaterials. Her publications in leading journals highlight influential contributions to chemical vapor deposition techniques, doped graphene architectures, and environmentally relevant inorganic chemistry. Her research has received strong global recognition and is widely cited across the materials science community. She collaborates extensively with interdisciplinary teams, contributing to advances in two-dimensional materials, sustainable material development, and functional nanostructures for emerging technologies. Her work bridges fundamental chemistry and practical applications, supporting progress in electronics, environmental safety, and next-generation material engineering. Through active research engagement and international cooperation, she continues to strengthen scientific understanding and its broader societal benefits.

Citation Metrics (Scopus)

500
400

300

200
100

0

Citations

477

Documents

9

h-index

7

Citations

Documents

h-index

View Scopus Profile
 View Google Scholar Profile
 View ORCID Profile

Featured Publications


Graphene transfer methods: A review

– Nano Research, 2021 (Cited by: 243)


Advances and trends in chemically doped graphene

– Advanced Materials Interfaces, 2020 (Cited by: 153)


Evaluation of the mobility and pollution index of essential/toxic metals in paddy soil

– Ecotoxicology & Environmental Safety, 2018 (Cited by: 59)

Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Published on by NESIN Awards

Mr. Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Universidade Federal da Bahia | Brazil

Mr. Valmir Rastely-Junior is a distinguished physician specializing in infectious diseases, pediatrics, and neuropediatrics, with an MD from the Federal University of Bahia (UFBA, 2015). He has accumulated extensive clinical and research experience, focusing on child health, congenital Zika syndrome, antimicrobial resistance, and public health inequities, integrating multidisciplinary care with evidence-based interventions. His professional trajectory includes work at Fiocruz Bahia on neurodevelopmental studies, epidemiologic surveillance, teratogen information services, and COVID-19 teleadvice programs. He has been instrumental in technology-driven initiatives such as Telecoronavírus (UFBA) and Artificial Intelligence as a Service for Combating COVID-19 (Rede CoVida/Cidacs Fiocruz), emphasizing the translation of research into practical, community-focused solutions. Mr. Rastely-Junior’s research interests center on infectious-disease–driven child health, neurodevelopmental outcomes in congenital infections, health disparities, and AI-supported clinical and epidemiological tools. He possesses strong research skills, including clinical study design, epidemiologic analysis, bibliometric synthesis, and international collaborative research, demonstrated through six peer-reviewed publications in Scopus and PubMed-indexed journals, three joint research projects, two conference presentations, and mentorship of research scholars. His work has earned eight awards and recognitions, including first-place honors at Fiocruz Bahia and an honorable mention in the International Balint Award/Ascona Prize, reflecting both scientific excellence and societal impact. Mr. Rastely-Junior is an active member of 16 professional bodies, contributing to editorial, review, and volunteer initiatives that promote knowledge dissemination and community engagement. In conclusion, his blend of clinical expertise, innovative research, international collaborations, and commitment to evidence-based public health positions him as a promising leader in global biomedical research, capable of advancing high-impact publications, AI-enabled solutions, and mentorship programs that enhance healthcare outcomes and scientific standards worldwide. 27 Citations | 3 Documents | 2 h-index.

Profiles: Google Scholar | Scopus | ORCID | LinkedIn

Featured Publications

  1. Aguilar Ticona, J. P., Nery Jr, N., Doss-Gollin, S., Gambrah, C., Lessa, M., … Rastely-Junior, V. N. (2021). Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly. PLoS One, 16(9), e0256444. https://doi.org/10.1371/journal.pone.0256444. Cited by: 26

  2. Nery Jr, N., Aguilar Ticona, J. P., Gambrah, C., Doss-Gollin, S., Aromolaran, A., … Rastely-Junior, V. N. (2021). Social determinants associated with Zika virus infection in pregnant women. PLoS Neglected Tropical Diseases, 15(7), e0009612. https://doi.org/10.1371/journal.pntd.0009612. Cited by: 14

  3. Aromolaran, A., Araujo, K., Ladines-Lim, J. B., Nery Jr, N., do Rosário, M. S., … Rastely-Junior, V. N. (2022). Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. International Journal of Infectious Diseases, 120, 201–204. https://doi.org/10.1016/j.ijid.2022.06.021. Cited by: 6

  4. Mattos, A. M., Rastely-Junior, V. N., Pires, M. M., Aguilar, J. P., Lessa, M. S. A., Regis, C., … (2023). Predictors of neurodevelopment in microcephaly associated with congenital Zika Syndrome: A prospective study. Children, 10(12), 1831. https://doi.org/10.3390/children10121831. Cited by: 3

  5. Brito, L. B., Rastely-Junior, V. N., Browne, E. S., Nery Júnior, N. R. R., … (2016). Sinais e sintomas de zika-virus em gestantes internadas em um Hospital Público de referência da Bahia. Cited by: 2

 

Kausik Paul | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Dr . Kausik Paul | Immunology and Microbiology | Best Researcher Award

Project Scientist at Cedars-Sinai Medical Center , United States

Dr. Kausik Paul is a dedicated immunologist and project scientist at Cedars-Sinai Medical Center, specializing in red blood cell (RBC) alloimmunization and transfusion medicine. With a strong academic foundation in microbiology, biophysics, and immunology, he has contributed significantly to understanding immune responses in lupus and transfusion settings. His work includes notable first-author publications in Frontiers in Immunology and Antioxidants, as well as multiple conference presentations on alloantibody responses in lupus mouse models. Dr. Paul has a strong history of scientific productivity, including peer-reviewed publications, patents, and impactful collaborative research. His technical expertise spans flow cytometry, cytokine profiling, and qPCR, supporting his efforts to refine personalized transfusion protocols. While he could further enhance his profile by securing independent funding and leading larger-scale projects, his current contributions reflect originality, depth, and clinical relevance. Dr. Paul is a highly suitable candidate for the Best Researcher Award, with clear potential for continued impactful research.

Professional Profile 

Education🎓

Dr. Kausik Paul has a comprehensive and interdisciplinary educational background that has shaped his expertise in immunology and transfusion medicine. He began his academic journey with a Bachelor of Science in Microbiology, followed by a Master’s degree in Biophysics from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad. His growing interest in immune mechanisms led him to pursue a Ph.D. in Infectious Diseases and Immunology at IICB-CSIR and Jadavpur University, Kolkata, where he developed a strong foundation in antigen-antibody interactions and immune response regulation. To further expand his knowledge, Dr. Paul completed postdoctoral training in immunology at the University of Manitoba and the University of Arizona, gaining exposure to advanced immunological techniques and research models. His education has been integral to his development as a researcher, equipping him with the scientific rigor and technical skills necessary to investigate complex immune responses, particularly in the context of RBC alloimmunization and autoimmune conditions like lupus.

Professional Experience📝

Dr. Kausik Paul has amassed extensive professional experience in immunology, with a focus on transfusion medicine and red blood cell (RBC) alloimmunization. Currently serving as a Project Scientist at Cedars-Sinai Medical Center since 2022, he leads research exploring immune responses to RBC antigens, particularly in lupus models. Prior to this, he held faculty positions as an Assistant Professor at Seacom Skills University and Glocal University, where he was involved in both teaching and research. His earlier postdoctoral appointments at the University of Manitoba and the University of Arizona enriched his expertise in cellular immunology and advanced laboratory techniques. Throughout his career, Dr. Paul has demonstrated a strong command of experimental approaches such as flow cytometry, cytokine profiling, and qPCR. His roles have included both independent and collaborative research, manuscript writing, and conference presentations. These experiences have collectively positioned him as a skilled and impactful researcher in the field of immunological science.

Research Interest🔎

Dr. Kausik Paul’s research interests lie primarily in immunology, with a specialized focus on red blood cell (RBC) alloimmunization, autoimmune disorders, and transfusion medicine. He is particularly interested in understanding the molecular and cellular mechanisms behind alloantibody formation in response to RBC antigens, especially in autoimmune conditions such as lupus. His current research explores the roles of type 1 and type 2 interferons in modulating immune responses to transfused RBCs, aiming to develop personalized transfusion strategies that minimize alloimmunization risk. Dr. Paul is also deeply invested in investigating inflammatory cytokine profiles, interferon-stimulated gene expression, and antigen presentation processes. His long-term goal is to translate basic immunological findings into clinically applicable solutions that enhance patient outcomes during blood transfusion therapies. Through the integration of advanced immunological techniques and animal models, Dr. Paul aspires to contribute significantly to the field of transfusion science and improve therapeutic protocols for immunocompromised

Award and Honor🏆

Dr. Kausik Paul has been recognized with several prestigious awards and honors throughout his academic and research career, reflecting his dedication and contributions to the field of immunology. He was the recipient of the Senior Research Fellowship (SRF) from the Council of Scientific and Industrial Research (CSIR), India, in 2007, which is awarded to outstanding doctoral candidates in scientific research. In 2006, he was also granted a Senior Research Fellowship through a project funded by the Department of Biotechnology (DBT), India, underscoring his involvement in high-impact research initiatives. Earlier, in 2003, Dr. Paul received a Research Fellowship under a project funded by the Department of Science and Technology (DST), India, during the initial stages of his research career. These honors not only highlight his scientific capabilities but also demonstrate the recognition he has earned from national funding agencies for his commitment to advancing biomedical research and innovation in immunology and related fields.

Research Skill🔬

Dr. Kausik Paul possesses a comprehensive range of research skills that span basic and translational immunology, with a strong emphasis on red blood cell (RBC) alloimmunization and autoimmune disease models. He is highly proficient in advanced laboratory techniques, including flow cytometry for cellular analysis and crossmatching, quantitative PCR for gene expression profiling, and ELISA-based assays for measuring cytokines and immune responses. His expertise extends to in vivo experimental design using mouse models, particularly in lupus research, where he investigates type 1 and type 2 interferon pathways and their influence on alloantibody production. Dr. Paul also demonstrates strong analytical skills in data interpretation, experimental troubleshooting, and scientific writing, as evidenced by his numerous publications and conference presentations. His ability to integrate immunological theory with practical experimentation has been instrumental in uncovering novel insights into transfusion medicine. Collectively, his technical competencies and critical thinking make him a valuable contributor to biomedical research.

Conclusion💡

Dr. Kausik Paul demonstrates a strong case for the Best Researcher Award, especially within the domains of transfusion medicine and immunology. He has a proven track record of impactful research, interdisciplinary collaboration, innovation (patents), and consistent engagement with the global scientific community through publications and conferences.

While there are areas he can build on—especially independent funding, mentorship, and institutional leadership—his current trajectory and recent accomplishments, particularly in a high-impact field like lupus-related RBC alloimmunization, are highly commendable.

Publications Top Noted✍

  • Title: Activated T lymphocytes migrate toward the cathode of DC electric fields in microfluidic devices
    Authors: J Li, S Nandagopal, D Wu, SF Romanuik, K Paul, DJ Thomson, F Lin
    Year: 2011
    Citations: 91

  • Title: N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl⁺ cells by endothelial nitric oxide synthase-mediated production of nitric oxide
    Authors: S Rakshit, J Bagchi, L Mandal, K Paul, D Ganguly, S Bhattacharjee, …
    Year: 2009
    Citations: 48

  • Title: Leishmania donovani Infection of Human Myeloid Dendritic Cells Leads to a Th1 Response in CD4⁺ T Cells from Healthy Donors and Patients with Kala-Azar
    Authors: M Ghosh, L Mandal, S Maitra, S Rakshit, K Paul, J Bagchi, D Ganguly, …
    Year: 2006
    Citations: 30

  • Title: Granulocyte–macrophage colony‐stimulating factor drives monocytes to CD14^low CD83⁺ DCSIGN⁻ interleukin‐10‐producing myeloid cells with differential …
    Authors: D Ganguly, K Paul, J Bagchi, S Rakshit, L Mandal, G Bandyopadhyay, …
    Year: 2007
    Citations: 26

  • Title: Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis
    Authors: S Mallick, S Halder, A Dutta, S Dey, K Paul, S Maiti, C Bandyopadhyay, …
    Year: 2013
    Citations: 22

  • Title: Dendritic cells and antigen trapping technology—a revolution in vaccine/immunotherapy strategy
    Authors: C Pal, D Ganguly, K Paul, S Pal
    Year: 2007
    Citations: 5

  • Title: Distinct RBC alloantibody responses in type 1 interferon-dependent and -independent lupus mouse models
    Authors: K Paul, R Hernández-Armengol, JY Lee, CY Chang, T Shibata, …
    Year: 2024
    Citations: 3

  • Title: Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)
    Authors: S Bandyopadhyay, BC Pal, J Parasuraman, S Roy, JB Chakrabotry, …
    Year: 2016
    Citations: 1

  • Title: Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent …
    Authors: JB Chakraborty, SK Mahato, K Joshi, V Shinde, S Rakshit, N Biswas, …
    Year: 2012
    Citations: 1

Shadi Hamoud | Heart diseases | Best Researcher Award

Published on by NESIN Awards

Dr. Shadi Hamoud | Heart diseases | Best Researcher Award

Head, research unit at Rambam Health Care Campus, Israel

Dr. Shadi Hamoud is a distinguished physician, researcher, and academic leader specializing in internal medicine, atherosclerosis, and novel cardiovascular treatments. With an MD (cum laude) from Hebrew University and an MPA from the University of Haifa, he serves as a Clinical Senior Lecturer at the Technion-Israel Institute of Technology and Deputy Director of Internal Medicine E at Rambam Medical Center. His research focuses on lipoproteins oxidation, heparanase enzyme roles in kidney and liver diseases, and international clinical trials on cardiovascular medicine, diabetes, and COVID-19 therapies. He has mentored numerous graduate students, contributed extensively to clinical research, and secured competitive research grants. His leadership extends to ethics committees, pharmaceutical consulting, and medical education. Recognized with multiple teaching excellence awards, he actively contributes to professional societies, public health initiatives, and medical advancements, making him a strong candidate for the Best Researcher Award. However, a broader international research collaboration could further enhance his impact.

Professional Profile

Education🎓

Dr. Shadi Hamoud holds an MD degree with cum laude honors from the Hebrew University of Jerusalem, demonstrating his strong academic foundation in medicine. He further pursued an Executive Master of Public Administration (MPA) at the University of Haifa, equipping him with leadership and administrative skills essential for medical research and healthcare management. Throughout his education, he developed a keen interest in internal medicine, atherosclerosis, and cardiovascular diseases, which later became the core of his research. His academic journey also includes specialized training in clinical research, medical ethics, and translational medicine, enhancing his expertise in both theoretical and practical aspects of healthcare. His commitment to continuous learning is evident in his involvement with international research projects and advanced training programs. His diverse educational background not only strengthens his medical proficiency but also enables him to contribute significantly to healthcare policy, medical education, and clinical advancements in cardiovascular and metabolic diseases.

Professional Experience 📝

Dr. Shadi Hamoud is a distinguished physician and researcher specializing in internal medicine, atherosclerosis, and cardiovascular diseases. He has extensive professional experience in clinical practice, medical research, and healthcare administration. As a senior physician, he has worked in leading hospitals, diagnosing and treating complex cardiovascular and metabolic disorders. His expertise extends to translational medicine, bridging the gap between research and patient care. Dr. Hamoud has also been actively involved in clinical trials, contributing to groundbreaking studies on lipid metabolism and atherosclerosis. His leadership roles in medical institutions and research committees reflect his dedication to advancing medical knowledge and improving patient outcomes. Additionally, he has collaborated with international experts, publishing numerous high-impact research papers in peer-reviewed journals. His commitment to medical education is evident through mentoring young researchers and medical students, ensuring the next generation of healthcare professionals is well-equipped to tackle emerging challenges in cardiovascular and metabolic diseases.

Research Interest🔎

Dr. Shadi Hamoud’s research interests focus on cardiovascular diseases, atherosclerosis, and lipid metabolism, with a particular emphasis on the mechanisms underlying cardiovascular risk factors. His work explores the role of cholesterol, inflammation, and metabolic disorders in the development of atherosclerosis, aiming to identify novel therapeutic targets for prevention and treatment. He is also deeply interested in translational medicine, bridging laboratory research with clinical applications to enhance patient care. Dr. Hamoud has contributed significantly to studies on lipid-lowering therapies, biomarkers for cardiovascular risk assessment, and the impact of lifestyle modifications on heart health. His research extends to the intersection of metabolic disorders such as diabetes and obesity with cardiovascular disease, seeking innovative strategies to reduce morbidity and mortality. Through collaborations with international research institutions, he continues to advance scientific understanding in cardiovascular medicine, striving to develop more effective diagnostic tools and personalized treatment approaches for patients with cardiovascular and metabolic diseases.

Award and Honor🏆

Dr. Shadi Hamoud has received numerous awards and honors in recognition of his outstanding contributions to cardiovascular research and medicine. His excellence in scientific innovation and dedication to improving cardiovascular health have earned him prestigious accolades from medical and research institutions worldwide. He has been honored with awards for his groundbreaking work in lipid metabolism and atherosclerosis, highlighting his impact on the field. Additionally, Dr. Hamoud has received research grants and fellowships that have supported his pioneering studies in cardiovascular disease prevention and treatment. His contributions have been recognized through invitations to speak at international conferences, where he has shared his expertise with the global medical community. He has also been acknowledged for his mentorship and leadership in guiding young researchers in the field. Through his achievements, Dr. Hamoud continues to make significant advancements in cardiovascular medicine, earning widespread recognition for his dedication to scientific excellence and patient care.

Research Skill🔬

Dr. Shadi Hamoud possesses exceptional research skills that have significantly advanced the field of cardiovascular medicine. His expertise spans a wide range of methodologies, including molecular biology techniques, lipid metabolism analysis, and advanced imaging technologies for cardiovascular assessment. He is proficient in designing and conducting clinical and laboratory-based studies, utilizing statistical tools to analyze complex datasets, and translating research findings into clinical applications. Dr. Hamoud excels in grant writing and securing research funding, demonstrating his ability to lead high-impact projects. His strong problem-solving skills and critical thinking enable him to address challenging scientific questions effectively. Additionally, his collaborative approach fosters interdisciplinary research, enhancing innovation in cardiovascular disease prevention and treatment. With a keen eye for detail and a commitment to scientific integrity, Dr. Hamoud consistently produces high-quality research that contributes to medical advancements, making him a highly respected figure in the scientific and medical communities.

Conclusion💡

Dr. Shadi Hamoud is a highly suitable candidate for the Best Researcher Award, given his exceptional contributions to cardiovascular research, clinical medicine, and medical education. His extensive mentorship, leadership in international clinical trials, and commitment to translational medicine make him a strong contender. Strengthening his global visibility and publishing more in top-tier journals could further enhance his profile.

Publications Top Noted✍️

  • Title: Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in αMUPA Mice and HEK-293 Cells
    Authors: H.A. Alkhaleq, Heba Abd; I. Hacker, Israel; T. Karram, Tony; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024

  • Title: Involvement of Heparanase in the Pathogenesis of Acute Pancreatitis: Implication of Novel Therapeutic Approaches
    Authors: D.B. Hamo-Giladi, Dalit B.; A. Fokra, Ahmad; E. Sabo, Edmond; Z.A. Abassi, Zaid A.; I. Khamaysi, Iyad
    Year: 2024

  • Title: Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury
    Authors: H.A. Alkhaleq, Heba Abd; S. Hamoud, Shadi; I. Hacker, Israel; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024
    Citations: 2

 

Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Published on by NESIN Awards

Dr. Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Investigadora Principal Sénior-Júnior at Vall Hebron Institut Research VHIR, Spain

Dr. Cristina Solé Marcé is a distinguished researcher specializing in systemic lupus erythematosus (SLE) with over a decade of experience in clinical-translational research. She holds dual degrees in Chemistry and Biochemistry, a PhD with international distinction, and a master’s in Synthesis and Catalysis from Universitat Rovira i Virgili. As a Senior-Junior Principal Investigator at Vall d’Hebron Research Institute, her work focuses on identifying novel biomarkers, developing personalized treatments, and exploring innovative therapies such as CAAR-T cells for lupus nephritis. She has published 31 scientific articles, with 94% as first, last, or corresponding author, and has collaborated with leading institutions, startups, and pharmaceutical companies. A recipient of the 2023 Health Science Award from the Institut d’Estudis Catalans, she is actively engaged in clinical trials, mentorship, and public science outreach. Dr. Solé’s contributions significantly advance lupus research, making her an outstanding candidate for the Women Researcher Award.

Professional Profile 

Education

Dr. Cristina Solé Marcé has a strong academic background in chemistry, biochemistry, and translational medicine. She earned dual degrees in Chemistry and Biochemistry from Universitat Rovira i Virgili, followed by a master’s in Synthesis and Catalysis at the same institution. She later pursued a PhD with international distinction, focusing on innovative research in systemic lupus erythematosus (SLE). Her doctoral work provided a solid foundation for her career in clinical and translational research, particularly in autoimmune diseases. Committed to continuous learning, Dr. Solé has engaged in specialized training programs, including those in biomarker discovery and personalized medicine. Her educational journey, complemented by interdisciplinary expertise and hands-on research, has positioned her as a leading scientist in lupus research. With extensive collaborations and contributions to high-impact publications, her academic achievements continue to shape advancements in precision medicine and novel therapeutic approaches for lupus and related autoimmune disorders.

Professional Experience

Dr. Cristina Solé Marcé is an accomplished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE). She has extensive experience in translational and clinical research, focusing on biomarker discovery and personalized medicine. Throughout her career, she has collaborated with leading research institutions and hospitals, contributing to the advancement of novel diagnostic and therapeutic strategies. Dr. Solé has played a key role in multidisciplinary research projects, integrating molecular biology, immunology, and clinical data to improve patient outcomes. She has also published extensively in high-impact scientific journals and presented her findings at international conferences. Her expertise extends to project management, mentorship of young researchers, and securing competitive research funding. Currently, she continues to drive innovation in lupus research, leveraging her knowledge in precision medicine to develop targeted treatments. Her work has had a significant impact on improving the understanding and management of autoimmune diseases worldwide.

Research Interest

Dr. Cristina Solé Marcé’s research interests focus on autoimmune diseases, with a particular emphasis on systemic lupus erythematosus (SLE). Her work explores the molecular mechanisms underlying disease pathogenesis, aiming to identify novel biomarkers for early diagnosis, prognosis, and treatment response. She is deeply involved in translational research, integrating clinical data with advanced molecular and immunological techniques to develop personalized therapeutic strategies. Dr. Solé is particularly interested in the role of epigenetics, gene expression, and immune system dysregulation in lupus and related disorders. Her research also extends to precision medicine approaches, seeking to tailor treatments to individual patients based on their genetic and molecular profiles. She collaborates with multidisciplinary teams, including clinicians, bioinformaticians, and immunologists, to translate laboratory discoveries into clinical applications. Through her work, Dr. Solé aims to enhance disease management and improve the quality of life for patients suffering from autoimmune conditions.

Award and Honor

​Dr. Cristina Solé Marcé is a distinguished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Since 2021, she has served as a Senior-Junior Principal Investigator in the Rheumatology team at the Systemic Lupus Erythematosus Unit of the Vall Hebron Research Institute (VHIR). Prior to this role, she dedicated six years as a postdoctoral researcher within the same unit. Her research endeavors focus on enhancing patient outcomes by identifying novel biomarkers to monitor disease status non-invasively and exploring the effects of new drugs and molecular pathways involved in various clinical manifestations. This work has led to multiple publications in internationally recognized journals and invitations to present at prestigious conferences such as the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR).

Research Skill

Dr. Cristina Solé Marcé possesses a diverse range of research skills, particularly in the fields of autoimmune diseases, biomarker discovery, and drug synthesis. She has extensive experience in molecular biology techniques, biochemical assays, and analytical chemistry, which she applies to her studies on systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Her expertise includes non-invasive biomarker identification to improve disease monitoring and understanding the mechanisms of action of novel therapeutic agents. With a strong background in synthetic chemistry, she has worked on the enantioselective synthesis of drugs and the development of anticancer compounds. Additionally, she is skilled in experimental design, data analysis, and scientific communication, with multiple publications in high-impact journals and presentations at international conferences such as ACR and EULAR. Her interdisciplinary approach, combining chemistry, biochemistry, and immunology, enables her to contribute significantly to translational research and patient-centered advancements in rheumatology.

Conclusion

Dr. Cristina Solé Marcé is a highly accomplished researcher with an impressive track record in autoimmune disease research, particularly lupus. Her combination of scientific excellence, leadership, international collaboration, and patient engagement makes her a compelling candidate for the Women Researcher Award. Strengthening her funding profile and expanding her research applications could further solidify her impact. Given her current achievements, she is well-deserving of recognition through this award.

Publications Top Noted

  • Solé et al., 2025 – Topical miRNA Delivery via Elastic Liposomal Formulation: A Promising Genetic Therapy for Cutaneous Lupus Erythematosus. Int. J. Mol. Sci. DOI: 10.3390/ijms26062641
  • Sandoval, Solé et al., 2024 – Neuropilin-1 as a Key Molecule for Renal Recovery in Lupus Nephritis: Insights from an NZB/W F1 Mouse Model. Int. J. Mol. Sci. DOI: 10.3390/ijms252111364
  • Solé et al., 2024 – Precise Targeting of Autoantigen-Specific B Cells in Lupus Nephritis with Chimeric Autoantibody Receptor T Cells. Int. J. Mol. Sci. DOI: 10.3390/ijms25084226
  • Solé et al., 2023 – Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS). Int. J. Mol. Sci. DOI: 10.3390/ijms241411607
  • Solé et al., 2023 – Downregulation of miR-885-5p Promotes NF-κB Pathway Activation and Immune Recruitment in Cutaneous Lupus Erythematosus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2022.08.036
  • Solé et al., 2022 – Humoral and Cellular Response in Convalescent COVID-19 Lupus Patients. Sci. Rep. DOI: 10.1038/s41598-022-17334-5
  • Domingo, Solé et al., 2021 – Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways. Biomedicines. DOI: 10.3390/biomedicines9121857
  • Domingo, Solé et al., 2020 – Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms. Dermatology. DOI: 10.1159/000508672
  • Domingo, Solé et al., 2020 – MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus, and Atopic Dermatitis. Cells. DOI: 10.3390/cells9122656
  • Garcia-Vives, Solé et al., 2020 – The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis. Int. J. Mol. Sci. DOI: 10.3390/ijms21041372
  • Solé et al., 2019 – MicroRNA Expression Profiling Identifies miR-31 and miR-485-3p as Regulators in the Pathogenesis of Discoid Cutaneous Lupus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2018.07.026

Jian Han | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Dr. Jian Han | Medicine and Dentistry | Best Researcher Award

Orthopedic Surgeon at Department of Orthopaedic Surgery, The First People’s Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China

Dr. Jian Han is a distinguished orthopedic surgeon specializing in orthopedic surgery at The First People’s Hospital of Huzhou, China. His research focuses on reverse total shoulder arthroplasty, bone-to-tendon healing, and innovative biomaterials, with numerous high-impact publications in prestigious international journals. His work on 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites has significantly advanced orthopedic treatments. Through extensive collaborations with leading researchers, he has contributed to improving surgical techniques and patient outcomes. His studies on extracorporeal shockwave therapy, bone marrow aspirate concentrate, and tendon healing mechanisms demonstrate his commitment to innovative and clinically relevant research. While his expertise is highly specialized, expanding his interdisciplinary collaborations and leadership roles in academic societies could further enhance his impact. With a strong publication record and dedication to advancing orthopedic medicine, Dr. Han stands out as a leading researcher in his field, making significant contributions to both academia and clinical practice.

Professional Profile 

Education

Dr. Jian Han pursued his medical education and specialized training in orthopedic surgery, establishing a strong foundation in musculoskeletal medicine and surgical techniques. He completed his medical degree and orthopedic residency at prestigious institutions, where he developed expertise in advanced orthopedic procedures, including reverse total shoulder arthroplasty and bone-to-tendon healing. His education emphasized both clinical excellence and research innovation, leading him to actively engage in studies on biomaterials, regenerative medicine, and orthopedic biomechanics. Throughout his academic journey, he collaborated with renowned experts, contributing to groundbreaking research in orthopedic surgery. Dr. Han’s commitment to lifelong learning is evident in his extensive publication record and his continuous efforts to integrate cutting-edge scientific advancements into clinical practice. His educational background has played a crucial role in shaping his expertise, enabling him to make significant contributions to orthopedic research and patient care.

Professional Experience

Dr. Jian Han is an experienced orthopedic surgeon currently serving in the Department of Orthopaedic Surgery at The First People’s Hospital of Huzhou, China. With a strong clinical and research background, he specializes in reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His expertise extends to advanced surgical techniques and the integration of innovative biomaterials to improve patient outcomes. Throughout his career, Dr. Han has collaborated with leading orthopedic researchers, contributing to high-impact studies on 3D-printed biomaterials, recombinant human parathyroid hormone biocomposites, and bone marrow aspirate concentrate therapy. His work has been published in prestigious international journals, reinforcing his role as a key contributor to orthopedic advancements. In addition to his clinical responsibilities, he is actively involved in research projects that aim to enhance musculoskeletal treatment strategies. Dr. Han’s dedication to both patient care and scientific innovation makes him a distinguished figure in the field of orthopedic surgery.

Research Interest

Dr. Jian Han’s research interests lie in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation, with a particular focus on reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His work explores advanced surgical techniques and novel therapeutic approaches to enhance patient outcomes. He has extensively studied 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites, contributing to the development of innovative solutions for tendon and bone regeneration. Dr. Han is also interested in extracorporeal shockwave therapy, bone marrow aspirate concentrate therapy, and their impact on musculoskeletal healing. His research integrates biomechanics, tissue engineering, and molecular biology to advance orthopedic treatment strategies. By collaborating with leading experts in the field, he continuously explores new frontiers in orthopedic implants, prosthetic development, and minimally invasive surgical techniques. Dr. Han’s research aims to bridge the gap between clinical practice and scientific innovation, improving the effectiveness and longevity of orthopedic procedures.

Award and Honor

Dr. Jian Han has received several awards and honors in recognition of his contributions to orthopedic surgery and musculoskeletal research. His groundbreaking work in reverse total shoulder arthroplasty, bone-to-tendon healing, and biomaterials innovation has earned him accolades from prestigious medical and research institutions. He has been recognized for his high-impact publications in leading international journals, reflecting his dedication to advancing orthopedic medicine. Dr. Han has also received honors for his contributions to biomechanical research, regenerative medicine, and innovative surgical techniques, which have significantly improved patient outcomes. His collaborative studies with global experts have further solidified his reputation as a leading researcher in orthopedic surgery. In addition to his research achievements, he has been invited as a reviewer and speaker at international conferences, where he shares his expertise with the medical community. Dr. Han’s commitment to scientific excellence and innovation continues to earn him professional recognition and respect.

Research Skill

Dr. Jian Han possesses exceptional research skills in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation. His expertise includes advanced imaging techniques, biomechanical analysis, and molecular biology applications to study bone-to-tendon healing and joint reconstruction. He is proficient in 3D printing technology for biomedical applications, tissue engineering, and the development of bioactive scaffolds to enhance orthopedic treatments. Dr. Han has strong analytical and problem-solving abilities, enabling him to design and conduct clinical and experimental studies with precision. His skills in data analysis, statistical modeling, and biomechanical simulations allow him to validate surgical techniques and therapeutic interventions. He is also experienced in systematic literature reviews, grant writing, and peer-reviewed publishing, contributing significantly to orthopedic research. His ability to collaborate with multidisciplinary teams and integrate cutting-edge technologies like regenerative medicine and nanomaterials into his studies makes him a highly skilled and innovative orthopedic researcher dedicated to advancing patient care.

Conclusion

Dr. Jian Han is a highly competitive candidate for the Best Researcher Award due to his strong publication record, innovative research in orthopedic surgery, and international contributions. To further enhance his eligibility, demonstrating leadership, securing research funding, and expanding interdisciplinary collaborations would elevate his profile even more.

Publication Top Noted

Title: Bone Marrow Aspirate Concentrate Combined With an Appropriate Carrier Effectively Promotes Bone-Tendon Interface Healing in a Rabbit Model of Chronic Rotator Cuff Tear

Authors: Shengchen Han, Jian Han, Young-Kyu Kim, Hyeon Jang Jeong, Joo-Han Oh

Year: 2025

Ameneh Heidari | Chemistry | Best Researcher Award

Published on by NESIN Awards

Dr. Ameneh Heidari | Chemistry | Best Researcher Award

 University of Zabol, Iran

Dr. Ameneh Heidari is an Assistant Professor at the University of Zabol, Iran, with expertise in inorganic chemistry, particularly in the synthesis and characterization of complex metals, anticancer metallodrugs, and molecular modeling. She holds a Ph.D. from the University of Sistan & Balouchestan, where her research focused on Pd(II) antitumor complexes and their interactions with biomolecules. With a strong academic background, she has published extensively in peer-reviewed journals, contributing to fields like nanotechnology, bioinorganic chemistry, and drug interactions. She has also presented her work at conferences and continues to explore new metal-based anticancer agents. Dr. Heidari has received recognition for her academic excellence, including a first-place ranking among incoming Ph.D. students. In addition to her research, she has extensive teaching experience in inorganic and general chemistry. Her contributions to both academia and scientific research position her as a leading researcher in her field with a growing international impact.

Professional Profile

Education

Dr. Ameneh Heidari holds a Ph.D. in Inorganic Chemistry from the University of Sistan & Balouchestan, Iran (2017–2022), where she conducted research on Pd(II) antitumor complexes, focusing on their synthesis, characterization, and interactions with biomolecules like DNA and proteins using spectroscopic and computational methods. She earned her M.Sc. in Inorganic Chemistry from the same university (2005–2008), further building her expertise in metal complexes and coordination chemistry. Her academic journey began with a B.Sc. in Pure Chemistry (2000–2004), also from the University of Sistan & Balouchestan, where she developed a strong foundation in chemical principles and laboratory techniques. Throughout her education, Dr. Heidari has demonstrated academic excellence, ranking first among incoming Ph.D. students. Her rigorous training in inorganic and bioinorganic chemistry, combined with extensive research experience, has enabled her to contribute significantly to the fields of medicinal chemistry, nanoscience, and molecular modeling.

Professional Experience

Dr. Ameneh Heidari has a strong professional background in academia and research, with extensive experience in inorganic chemistry. She began her academic career as an Instructor at the University of Zabol, Iran (2008–2017), where she taught undergraduate courses in general and inorganic chemistry. After earning her Ph.D., she was promoted to Assistant Professor at the same university (2022–present), where she continues to teach and supervise research projects. Her expertise spans advanced inorganic chemistry, spectroscopy, group theory, and metal corrosion. In addition to teaching, Dr. Heidari has made significant contributions to scientific research, focusing on the synthesis and characterization of complex metals, molecular modeling, and anticancer metallodrugs. She has published extensively in high-impact journals and actively participates in research collaborations. With a strong commitment to both education and scientific innovation, Dr. Heidari has established herself as a dedicated educator and researcher in the field of inorganic and bioinorganic chemistry.

Research Interest

Dr. Ameneh Heidari’s research interests lie in the fields of inorganic and bioinorganic chemistry, with a strong focus on the synthesis and characterization of complex metal compounds. She is particularly interested in the development of anticancer metallodrugs, studying their interactions with biomolecules such as DNA and proteins to explore their potential as therapeutic agents. Her work also extends to molecular modeling, where she employs computational chemistry techniques to analyze and predict the behavior of metal complexes in biological systems. Additionally, she investigates artificial enzymes and their catalytic properties, aiming to design novel biomimetic systems with industrial and pharmaceutical applications. Another key area of her research is the study of metal corrosion, exploring ways to enhance the stability and efficiency of metallic materials. Through her interdisciplinary approach, Dr. Heidari aims to contribute to advancements in medicinal chemistry, nanotechnology, and material science, bridging the gap between fundamental chemistry and practical applications.

Award and Honor

Dr. Ameneh Heidari has received notable recognition for her academic excellence and research contributions. One of her most significant achievements is securing the first-place ranking among incoming Ph.D. students in 2018, reflecting her outstanding academic performance and expertise in inorganic chemistry. Her dedication to research, particularly in the fields of anticancer metallodrugs, molecular modeling, and metal complex synthesis, has earned her a strong reputation in the scientific community. In addition to her academic accolades, Dr. Heidari has contributed extensively to high-impact research publications and international conferences, further solidifying her standing as a distinguished researcher. Her commitment to advancing bioinorganic chemistry and nanotechnology continues to be recognized through her publications, collaborations, and ongoing research projects. With a focus on both fundamental and applied chemistry, she strives to develop innovative solutions in medicinal and materials science, positioning herself as a leading researcher in her field.

Research Skill

Dr. Ameneh Heidari possesses a diverse set of research skills in inorganic and bioinorganic chemistry, with expertise in the synthesis and characterization of complex metal compounds. She is proficient in spectroscopic techniques such as UV-Vis, FTIR, NMR, and fluorescence spectroscopy, which she utilizes to study metal-ligand interactions and biomolecular binding. Her skills extend to molecular modeling, including docking and molecular dynamics simulations, enabling her to predict and analyze the behavior of metal-based drugs in biological environments. She has experience in crystallography and electrochemical analysis, essential for understanding structural and redox properties of metal complexes. Additionally, Dr. Heidari is skilled in nanomaterial synthesis and functionalization, particularly in developing metal-based nanoparticles for biomedical applications. Her ability to integrate experimental and computational approaches allows her to conduct in-depth investigations into anticancer metallodrugs, artificial enzymes, and corrosion inhibitors. Her strong analytical, laboratory, and problem-solving skills make her a highly capable researcher.

Conclusion

Dr. Ameneh Heidari is a highly qualified researcher with a strong publication record, interdisciplinary expertise, and significant academic contributions. While there is room for further international recognition and funding opportunities, the candidate is well-suited for the Best Researcher Award, given their impactful and ongoing work in inorganic chemistry and medicinal applications.

Publications Top Noted

Title: Synthesis, characterization, experimental and theoretical studies of the interaction of new Zn(II) complexes with DNA as potential anticancer agents

Authors: Ameneh Heidari, Effat Dehghanian

Year: 2025

Citations: 0

Lars Blønd | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Dr. Lars Blønd | Medicine and Dentistry | Best Researcher Award

Senior Surgeon at Senior Surgeon, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon and researcher specializing in patellofemoral surgery. As the inventor of the Arthroscopic Deepening Trochleoplasty, he has made groundbreaking contributions to knee and shoulder arthroscopy. With over 40 peer-reviewed publications, book chapters, and a dedicated book on femoral trochlear dysplasia, his research has significantly impacted the field. He has held leadership roles, including President of the Danish Association of Sports Medicine and ESSKA Scientific Committee member, demonstrating his influence in orthopedic research. Additionally, he actively educates and trains surgeons worldwide through live surgeries and instructional courses. His work bridges clinical practice and research, ensuring direct patient care improvements. While expanding his multidisciplinary collaborations could enhance his impact, his dedication to advancing orthopedic surgery and mentoring the next generation of researchers makes him a highly deserving candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Lars Blønd’s educational journey reflects his commitment to excellence in medicine and orthopedic surgery. He graduated from gymnasium in 1981 before serving in the Danish Navy in 1982. He then pursued medical studies at the University of Copenhagen, earning his medical degree in 1991. Following this, he underwent extensive postgraduate training in orthopedic surgery across eight different hospitals between 1991 and 2002, ultimately becoming a certified specialist in orthopedic surgery in 2001. Furthering his expertise, he obtained a Certificate in Sports Medicine in 2003. His education laid the foundation for his specialization in arthroscopic surgery, particularly in knee and shoulder procedures. Throughout his career, Dr. Blønd has continued to refine his skills, engage in research, and contribute to advancements in patellofemoral surgery. His rigorous training, combined with years of hands-on experience, has established him as a leading figure in orthopedic surgery and medical education.

Professional Experience

Dr. Lars Blønd has an extensive and distinguished career in orthopedic surgery, specializing in arthroscopic procedures for the knee and shoulder. Since 2013, he has served as a senior surgeon at The Zealand University Hospital of Koege and Aleris Hospital while also working with the Danish Patient Safety Authority. Previously, he held leadership roles, including Chief Surgeon at GHP (2008–2013), Herlev University Hospital (2006–2008), and Gentofte University Hospital (2004–2006). His expertise extends to private healthcare, having worked as a consultant and chief surgeon at multiple private hospitals. Beyond clinical practice, he has contributed to sports medicine, serving as a team physician for the Superliga soccer team HB Køge FC. As an international educator, he has trained surgeons globally through live surgeries and instructional courses. His decades-long experience, leadership in orthopedic advancements, and dedication to patient care make him a highly respected figure in the field of orthopedic surgery.

Research Interest

Dr. Lars Blønd’s research primarily focuses on orthopedic surgery, with a strong emphasis on patellofemoral instability, knee biomechanics, and arthroscopic surgical techniques. He is widely recognized for his pioneering work in Arthroscopic Deepening Trochleoplasty, a procedure he developed to address trochlear dysplasia and recurrent patellar dislocations. His research explores innovative surgical methods to improve patient outcomes, including MPFL reconstruction, cartilage preservation, and treatment strategies for chronic anterior knee pain. Additionally, he has contributed to studies on sports-related injuries, exsanguination techniques, and advanced imaging for knee pathology assessment. His work also extends to regenerative medicine, particularly the use of adipose-derived stem cells for treating osteoarthritis. Through his numerous peer-reviewed publications, book chapters, and global conference presentations, Dr. Blønd has significantly advanced the understanding and treatment of knee conditions, making his research invaluable to the fields of orthopedic surgery and sports medicine.

Award and Honor

Dr. Lars Blønd has earned widespread recognition for his contributions to orthopedic surgery, particularly in the field of patellofemoral instability and arthroscopic procedures. While specific awards and honors are not explicitly listed, his leadership roles and memberships in esteemed medical societies, such as ESSKA and the Danish Society for Arthroscopic Surgery, highlight his influence and respect in the field. His pioneering work in developing the Arthroscopic Deepening Trochleoplasty technique has garnered international recognition, leading to invitations for live surgical demonstrations and educational courses worldwide. Additionally, his extensive contributions to medical literature, including over 40 peer-reviewed publications and multiple book chapters, demonstrate his scholarly impact. As a sought-after speaker at global conferences and a host for prestigious surgical training programs, Dr. Blønd’s work continues to shape modern orthopedic surgery. His dedication to research, education, and surgical innovation reflects the qualities of an esteemed medical professional worthy of high honors.

Research Skill

Dr. Lars Blønd possesses exceptional research skills, demonstrated by his extensive contributions to orthopedic literature and surgical innovation. With over 40 peer-reviewed publications, multiple book chapters, and a leading role in developing Arthroscopic Deepening Trochleoplasty, he has established himself as a key researcher in patellofemoral instability and knee biomechanics. His ability to conduct high-quality clinical studies, retrospective analyses, and surgical technique evaluations showcases his expertise in evidence-based medicine. Dr. Blønd’s research skills extend to advanced imaging interpretation, biomechanical assessments, and regenerative medicine, particularly in the use of adipose-derived stem cells for osteoarthritis treatment. His involvement in international research collaborations, editorial contributions, and live surgical demonstrations further highlights his analytical and problem-solving abilities. As a frequent speaker at global conferences and an educator in arthroscopic surgery, he integrates research with clinical practice, continuously advancing the field of orthopedic surgery through data-driven insights and innovative surgical approaches.

Conclusion

Dr. Lars Blønd is a highly suitable candidate for the Best Researcher Award. His extensive publication record, innovative surgical advancements, and contributions to orthopedic research and education make him a strong contender. While he could further expand his research scope and collaborations, his impact on patellofemoral surgery and sports medicine is undeniable, making him an exemplary researcher in his field.

Publications Top Noted

  • Exercise performance in elite male and female sailors
    Authors: Larsson, B., Beyer, N., Bay, P., Blønd, L., Aagaard, P., and Kjaer, M.
    Year: 1996
    Citation: Int. J Sports Med. 17: 504-508

  • Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes
    Authors: Blønd, L. and Hansen, L.
    Year: 1998
    Citation: Acta Orthop Belg. 64: 393-400

  • Injuries caused by falling soccer goalposts in Denmark
    Authors: Blønd, L. and Hansen, L. B.
    Year: 1999
    Citation: Br. J Sports Med. 33: 110-112

  • Scintigraphic method for evaluation of reductions in local blood volumes in human extremities
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2000
    Citation: Scand J Lab Clin Inv. 60;(5): 333-339

  • Exsanguination of lower limbs before surgery
    Authors: Blønd, L., Kirketerp-Moeller K, Sonne-Holm S, and Madsen J.L.
    Year: 2002
    Citation: Acta Orthop Scand. 73;(1): 89-92

  • Exsanguination of upper limbs before surgery
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2002
    Citation: JBJS (Br). 84;(4):489-491

  • Exsanguination of limbs in elderly before surgery: A comparison with young individuals
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Int. Orthop. 27;(2): 114-116

  • Bone marrow perfusion in healthy subjects assessed by scintigraphy after application of a tourniquet
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(4): 460-464

  • Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty
    Authors: Husted H., Blønd L., Sonne-Holm S., Holm G., Jacobsen T., Gebuhr P.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(6): 665-669

  • Clinical Consequences of Different Exsanguination Methods in Hand Surgery: A Double-blind Randomised Study
    Authors: Blønd L., Jensen NV., Søe-Nielsen NH.
    Year: 2008
    Citation: Journal of Hand Surgery (European Volume) 33; 475

  • Suprascapular Nerve Block or Interscalene Brachial Plexus Block for Pain Relief after Arthroscopic Acromioplasty
    Authors: Konradsen L., Kirkegaard PR., Larsen VH., Blønd L.
    Year: 2009
    Citation: Ambulatory Surgery 15-1

  • The arthroscopic deepening trochleoplasty
    Authors: Blønd L. and Schöttle P.
    Year: 2010
    Citation: Knee Surg Sports Traumatol Arthrosc 18(4):480-5

  • Development in sports medicine
    Authors: Blønd L.
    Year: 2012
    Citation: Ugeskr Laeger 174(12):783

  • Arthroscopic treatment for snapping scapula: a prospective case series
    Authors: Blønd L., & Rechter S.
    Year: 2014
    Citation: Eur J Orthop Surg & Traumatol 24(2):159-64

  • Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament for patients with recurrent patella dislocation and trochlear dysplasia
    Authors: Blønd L., & Haugegaard M.
    Year: 2014
    Citation: Knee Surg Sports Traumatol Arthrosc 22:2484–2490